Home / Inspections / 1162476

FDA Inspection 1162476 — Guardian Drug Co. Inc.

Guardian Drug Co. Inc. — FEI 2245306

The FDA completed an inspection of Guardian Drug Co. Inc. on February 17, 2022 in Dayton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 17, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Dayton, NJ (United States)

Facility

Other inspections at this facility

  • 1304382 (NAI Fri Jan 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1231141 (NAI Thu Nov 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1030766 (VAI Mon Nov 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 890734 (NAI Fri Aug 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 785448 (VAI Fri Jun 08 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources